Ocular Therapeutix Inc. (OCUL)
NASDAQ: OCUL
· Real-Time Price · USD
12.20
0.26 (2.22%)
At close: Oct 16, 2025, 3:59 PM
12.20
0.00%
After-hours: Oct 16, 2025, 07:25 PM EDT
2.22% (1D)
| Bid | 11.68 |
| Market Cap | 2.12B |
| Revenue (ttm) | 56.6M |
| Net Income (ttm) | -216.75M |
| EPS (ttm) | -1.26 |
| PE Ratio (ttm) | -9.68 |
| Forward PE | -8.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.25 |
| Volume | 2,721,212 |
| Avg. Volume (20D) | 2,666,510 |
| Open | 12.00 |
| Previous Close | 11.94 |
| Day's Range | 11.84 - 12.33 |
| 52-Week Range | 5.79 - 13.85 |
| Beta | 1.44 |
| Ex-Dividend Date | n/a |
About OCUL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OCUL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OCUL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsOcular Therapeutix Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+3.39%
Ocular Therapeutix shares are trading higher after...
Unlock content with
Pro Subscription
2 weeks ago
-6.7%
OCUL stock has given up its prior gain. Ocular Therapeutix shares were trading higher after the company raised $475M in a stock offering to fund eye disease drug trials.
